NYMC Faculty Publications
Heme Biosynthesis Modulation via Δ-Aminolevulinic Acid Administration Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension
Author Type(s)
Faculty
DOI
10.1152/ajplung.00155.2014
Journal Title
American Journal of Physiology. Lung Cellular and Molecular Physiology
First Page
L719
Last Page
28
Document Type
Article
Publication Date
4-1-2015
Abstract
This study examines how heme biosynthesis modulation with δ-aminolevulinic acid (ALA) potentially functions to prevent 21-day hypoxia (10% oxygen)-induced pulmonary hypertension in mice and the effects of 24-h organoid culture with bovine pulmonary arteries (BPA) with the hypoxia and pulmonary hypertension mediator endothelin-1 (ET-1), with a focus on changes in superoxide and regulation of micro-RNA 204 (miR204) expression by src kinase phosphorylation of signal transducer and activator of transcription-3 (STAT3). The treatment of mice with ALA attenuated pulmonary hypertension (assessed through echo Doppler flow of the pulmonary valve, and direct measurements of right ventricular systolic pressure and right ventricular hypertrophy), increases in pulmonary arterial superoxide (detected by lucigenin), and decreases in lung miR204 and mitochondrial superoxide dismutase (SOD2) expression. ALA treatment of BPA attenuated ET-1-induced increases in mitochondrial superoxide (detected by MitoSox), STAT3 phosphorylation, and decreases in miR204 and SOD2 expression. Because ALA increases BPA protoporphyrin IX (a stimulator of guanylate cyclase) and cGMP-mediated protein kinase G (PKG) activity, the effects of the PKG activator 8-bromo-cGMP were examined and found to also attenuate the ET-1-induced increase in superoxide. ET-1 increased superoxide production and the detection of protoporphyrin IX fluorescence, suggesting oxidant conditions might impair heme biosynthesis by ferrochelatase. However, chronic hypoxia actually increased ferrochelatase activity in mouse pulmonary arteries. Thus, a reversal of factors increasing mitochondrial superoxide and oxidant effects that potentially influence remodeling signaling related to miR204 expression and perhaps iron availability needed for the biosynthesis of heme by the ferrochelatase reaction could be factors in the beneficial actions of ALA in pulmonary hypertension.
Recommended Citation
Alhawaj, R., Patel, D., Kelly, M. R., Sun, D., & Wolin, M. S. (2015). Heme Biosynthesis Modulation via Δ-Aminolevulinic Acid Administration Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology, 308 (7), L719-28. https://doi.org/10.1152/ajplung.00155.2014